BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24991451)

  • 1. Cysteinyl leukotrienes and their receptors; emerging concepts.
    Kanaoka Y; Boyce JA
    Allergy Asthma Immunol Res; 2014 Jul; 6(4):288-95. PubMed ID: 24991451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of cysteinyl leukotrienes and their receptors in immune cell-related functions.
    Kanaoka Y; Austen KF
    Adv Immunol; 2019; 142():65-84. PubMed ID: 31296303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway.
    Ciccarelli R; D'Alimonte I; Santavenere C; D'Auro M; Ballerini P; Nargi E; Buccella S; Nicosia S; Folco G; Caciagli F; Di Iorio P
    Eur J Neurosci; 2004 Sep; 20(6):1514-24. PubMed ID: 15355318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
    Drazen JM
    Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene modifiers in the treatment of cardiovascular diseases.
    Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA
    J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cells.
    Kondeti V; Duah E; Al-Azzam N; Thodeti CK; Boyce JA; Paruchuri S
    PLoS One; 2013; 8(8):e71536. PubMed ID: 23977066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current state and future prospect of the therapeutic strategy targeting cysteinyl leukotriene metabolism in asthma.
    Yamamoto T; Miyata J; Arita M; Fukunaga K; Kawana A
    Respir Investig; 2019 Nov; 57(6):534-543. PubMed ID: 31591069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
    Sharma JN; Mohammed LA
    Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm.
    Di Gennaro A; Wågsäter D; Mäyränpää MI; Gabrielsen A; Swedenborg J; Hamsten A; Samuelsson B; Eriksson P; Haeggström JZ
    Proc Natl Acad Sci U S A; 2010 Dec; 107(49):21093-7. PubMed ID: 21078989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding roles for leukotrienes in airway inflammation.
    Peters-Golden M
    Curr Allergy Asthma Rep; 2008 Jul; 8(4):367-73. PubMed ID: 18606091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists.
    Mellor EA; Austen KF; Boyce JA
    J Exp Med; 2002 Mar; 195(5):583-92. PubMed ID: 11877481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cysteinyl-leukotrienes in abdominal aortic aneurysm.
    Araújo AC; Tang X; Haeggström JZ
    Prostaglandins Other Lipid Mediat; 2018 Nov; 139():24-28. PubMed ID: 30248405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileukotriene drugs: clinical application, effectiveness and safety.
    Riccioni G; Bucciarelli T; Mancini B; Di Ilio C; D'Orazio N
    Curr Med Chem; 2007; 14(18):1966-77. PubMed ID: 17691939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease.
    Wang XS; Wu AY; Leung PS; Lau HY
    Allergy; 2007 Jun; 62(6):620-7. PubMed ID: 17508965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H
    Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteinyl leukotriene receptors, old and new; implications for asthma.
    Laidlaw TM; Boyce JA
    Clin Exp Allergy; 2012 Sep; 42(9):1313-20. PubMed ID: 22925317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene generation and clinical implications.
    Arm JP
    Allergy Asthma Proc; 2004; 25(1):37-42. PubMed ID: 15055561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukotrienes in clinical development for asthma.
    Centanni S; Santus P
    Expert Opin Investig Drugs; 2002 Jan; 11(1):49-58. PubMed ID: 11772320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileukotriene agents for the treatment of lung disease.
    Scott JP; Peters-Golden M
    Am J Respir Crit Care Med; 2013 Sep; 188(5):538-44. PubMed ID: 23822826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl leukotrienes mediate the enhancing effects of indomethacin and aspirin on eosinophil production in murine bone marrow cultures.
    Elsas PX; Queto T; Mendonça-Sales SC; Elsas MI; Kanaoka Y; Lam BK
    Br J Pharmacol; 2008 Feb; 153(3):528-35. PubMed ID: 18037915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.